Your browser doesn't support javascript.
loading
Chk1 inhibition-induced BRCAness synergizes with olaparib in p53-deficient cancer cells.
Zhao, Yang; Zhou, Kehui; Xia, Xiangyu; Guo, Yajie; Tao, Li.
Affiliation
  • Zhao Y; Department of Pharmacy, College of Medicine, Yangzhou University, Yangzhou, China.
  • Zhou K; Department of Medicine, Linfen Vocational and Technical College, Linfen, Shanxi, China.
  • Xia X; Department of Pharmacy, College of Medicine, Yangzhou University, Yangzhou, China.
  • Guo Y; Department of Pharmacy, College of Medicine, Yangzhou University, Yangzhou, China.
  • Tao L; Department of Pharmacy, College of Medicine, Yangzhou University, Yangzhou, China.
Cell Cycle ; 22(2): 200-212, 2023 01.
Article in En | MEDLINE | ID: mdl-35959961
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms / Antineoplastic Agents Language: En Journal: Cell Cycle Year: 2023 Document type: Article Affiliation country: China Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms / Antineoplastic Agents Language: En Journal: Cell Cycle Year: 2023 Document type: Article Affiliation country: China Country of publication: United States